TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus June 6, 2014
TCL Archive Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More July 3, 1987
TCL Archive In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER March 20, 1992
TCL Archive Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds June 11, 1999
